Articles

  1. Cell Culture Media For Viral Vector Applications 11/3/2025

    Explore media solutions for viral vector production that support HEK293 and insect cells, with custom development, analytical testing, and scalable preparation tools to optimize performance.

  2. How Lipid Nanoparticles Enable Next-Gen Delivery 10/20/2025

    Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.

  3. Taking An Alternative Approach To Drug Delivery 10/20/2025

    Novel therapeutics are driving demand for alternative drug delivery methods. Explore the latest approaches and understand the formulation challenges and benefits for specific diseases.

  4. Spray Dried Dispersions In Controlled Release Formulations 10/16/2025

    Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.

  5. Translational Pharmaceutics® For First-In-Human Studies 10/16/2025

    Re-engineer your drug's path into clinical development and accelerate time to Proof-of-Concept. Real-time data guides rapid formulation iterations, minimizing drug substance use and lowering program risk.

  6. Human ADME Studies: Human Metabolism Data For Regulatory Submission 10/16/2025

    Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.

  7. Formulation Strategies For Poorly Soluble Molecules 10/15/2025

    As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.

  8. Developing Palatable, Age Appropriate Drug Products 10/15/2025

    Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.

  9. High Potency Handling Capabilities And Support 10/15/2025

    Highly potent APIs require stringent containment and precise manufacturing controls. Specialized facilities offer end-to-end development solutions and robust cross-contamination protections.

  10. Formulation Development Services 10/15/2025

    Quickly address critical formulation issues and optimizing performance. Explore services for small molecules and synthetic peptides across oral, topical, rectal, and parenteral routes.